Fig. 2From: Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trialStandard Protocol Items: Recommendations for Interventional Trials (SPIRIT) figureBack to article page